Marshall Wace’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-161,921
| Closed | -$6.14M | – | 2682 |
|
|
2024
Q1 | $6.14M | Buy |
161,921
+141,669
| +700% | +$5.37M | 0.01% | 811 |
|
|
2023
Q4 | $436K | Buy |
+20,252
| New | +$436K | ﹤0.01% | 1472 |
|
|
2022
Q2 | – | Sell |
-6,167
| Closed | -$355K | – | 3149 |
|
|
2022
Q1 | $355K | Buy |
6,167
+4,502
| +270% | +$259K | ﹤0.01% | 2224 |
|
|
2021
Q4 | $197K | Sell |
1,665
-10,968
| -87% | -$1.3M | ﹤0.01% | 2479 |
|
|
2021
Q3 | $2.51M | Sell |
12,633
-13,423
| -52% | -$2.67M | 0.01% | 1116 |
|
|
2021
Q2 | $4.53M | Sell |
26,056
-21,594
| -45% | -$3.76M | 0.02% | 787 |
|
|
2021
Q1 | $9.44M | Sell |
47,650
-2,080
| -4% | -$412K | 0.04% | 443 |
|
|
2020
Q4 | $9.78M | Buy |
49,730
+33
| +0.1% | +$6.49K | 0.05% | 326 |
|
|
2020
Q3 | $8.81M | Sell |
49,697
-260
| -0.5% | -$46.1K | 0.06% | 312 |
|
|
2020
Q2 | $11.6M | Buy |
49,957
+16,391
| +49% | +$3.79M | 0.08% | 228 |
|
|
2020
Q1 | $3.91M | Buy |
33,566
+230
| +0.7% | +$26.8K | 0.04% | 442 |
|
|
2019
Q4 | $6.37M | Buy |
33,336
+1,312
| +4% | +$251K | 0.04% | 415 |
|
|
2019
Q3 | $6.16M | Buy |
32,024
+5,676
| +22% | +$1.09M | 0.05% | 412 |
|
|
2019
Q2 | $4.51M | Buy |
26,348
+11,312
| +75% | +$1.94M | 0.04% | 506 |
|
|
2019
Q1 | $3.03M | Buy |
+15,036
| New | +$3.03M | 0.03% | 620 |
|